Journal article icon

Journal article

Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma

Abstract:
Context: Pheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors that frequently produce catecholamines. Catecholamine-induced cardiometabolic complications substantially contribute to increased morbidity and mortality in PPGL patients prior to surgical resection. Objective: To determine whether markers of elevated cardiometabolic risk persist in patients following PPGL resection. Methods: In this retrospective analysis of a multicenter cohort of patients with PPGLs participating in the prospective ProsPheo study and the ENS@T registry, cardiometabolic risk factors, including glycemic status, dyslipidemia, and body mass index (BMI), were assessed in patients with PPGL at diagnosis and during follow-up. Patients with a history of resected PPGL were compared to a control group with nonfunctioning adrenal adenomas from the ENS@T registry. Results: Patients with a present PPGL or a history of PPGL (n = 188), a metastatic PPGL (n = 27), or a known susceptibility gene pathogenic variant (PV) for the development of PPGL without a history of PPGL (n = 44) were included. We compared the asymptomatic PV carriers to patients with a history of PPGL: those with a history of PPGL showed a significantly higher prevalence of hyperglycemic disorders (P = .013) compared with asymptomatic PV carriers. In patients with a history of PPGL and at least 12 months of follow-up post surgery (n = 113), the prevalence of hyperglycemic disorders (P < .001), as well as the mean HbA1c (5.63%, SD 0.43%), were significantly higher, compared to a control group with nonfunctioning adrenal adenomas (n = 76) of similar age and BMI (HbA1c 5.45%, SD 0.40%; P = .004). Conclusion: Glycemic disturbances persist long-term after the resection of PPGL.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1210/clinem/dgae901

Authors


More by this author
Role:
Author
ORCID:
0000-0003-4555-8334
More by this author
Role:
Author
ORCID:
0000-0002-3499-5910
More by this author
Role:
Author
ORCID:
0000-0003-0772-1604
More by this author
Role:
Author
ORCID:
0000-0002-6932-333X


More from this funder
Funder identifier:
https://ror.org/018mejw64


Publisher:
Oxford University Press
Journal:
The Journal of Clinical Endocrinology & Metabolism More from this journal
Volume:
110
Issue:
9
Pages:
e2966-e2976
Publication date:
2025-01-02
DOI:
EISSN:
1945-7197
ISSN:
0021972X and 0021-972X


Language:
English
Keywords:
Source identifiers:
3195372
Deposit date:
2025-08-13
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP